CARLSBAD, Calif.--(BUSINESS WIRE)--ChinaBio® LLC and EBD Group will hold the third annual ChinaBio® Partnering Forum on May 11-12, 2011 at the Shangri-La Hotel in Beijing, China. This year an Innovation Showcase has been added to the event to highlight novel technology development in China.
The Innovation Showcase will feature over 30 top professors and researchers from China’s leading universities and institutes presenting their novel technologies to leading biotechnology dealmakers from around the world. Projects selected to present are from many of the top universities and institutes in greater China including Peking University, Shanghai Jiao Tong University, Hong Kong Polytechnic University, Shanghai University, Guangzhou Medical University, Chinese National Human Genome Center, Chinese Academy of Sciences, Peking Union Medical Sciences, among others. The list of accepted projects can be viewed at http://bit.ly/cbpf2011-IS.
Submissions are by invitation only and twenty projects have been selected to present thus far. Each professor chosen by the review committee will make a 15 minute presentation on their project during the ChinaBio Partnering Forum. Three of the projects will also be selected to receive a “Most Innovative Technology” award.
The Innovation Showcase was created in response to requests from pharma companies seeking early stage technology in China. ChinaBio’s research group identified 3,200 novel molecules patented in China, positioning China as a rich source of technology for multi-national pharmas seeking to fill their pipeline.
The ChinaBio® Partnering Forum is expected to attract over 650 attendees from around the world. Last year’s event attracted 560 delegates and generated over 650 one-on-one meetings, making it the largest and most productive partnering meeting in China. The Partnering Forum is an international event with 29% of the delegates coming from Europe and the US, and 1/3 of the delegates from companies’ top management (Chairman, CEO, President, etc.).
More information on ChinaBio® Partnering Forum 2011 may be found at www.CBPF2011.com.
About ChinaBio® LLC
Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of initiatives accelerating the globalization of China’s life science industry. ChinaBio has helped China companies raise nearly $400 million and global life science companies identify over 400 licensing and acquisition opportunities in China.
- Conferences: ChinaBio organizes the premier life science investment and partnering conferences in China, having attracted over 4,000 attendees.
- Consulting: ChinaBio works with global life science companies and China entrepreneurs to define and execute a successful global strategy.
- Transactions: ChinaBio helps companies secure partnerships and acquisitions and access private and government funding in China.
- Publishing: ChinaBio® Today is the most widely read online and email newsletter on China’s life science industry.
More information is available at www.chinabiollc.com.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe and BIO-Europe Spring®, the world's largest stand-alone life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, EBD Group’s North American partnering event
- EuroMedtech™, EBD Group’s new partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China co-produced with ChinaBio® LLC.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world. Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.